On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...